Biohaven Pharmaceutical
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -977 | -941 | ||
EBITDA | -187,470 | -176,174 | -331,818 | -181,794 |
EBIT | -189,931 | -178,168 | -333,772 | -182,735 |
Net Income | -186,843 | -160,304 | -319,771 | -179,504 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -170,791 | -141,887 | -170,747 | -103,077 |
Cash | 99,134 | 84,390 | 239,147 | 184,506 |
Basic Shares | 91,234 | 94,372 | 87,766 | 81,601 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $462,509 |
Gross Profit | -3,369 | -1,386 | 370,845 | |
EBITDA | -885,111 | -429,139 | -462,799 | -217,507 |
EBIT | -436,051 | -464,185 | -218,900 | |
Net Income | -846,422 | -408,168 | -570,279 | -213,796 |
Net Change In Cash | 0 | 0 | 0 | 462,509 |
Cost of Revenue | 40,301 | |||
Free Cash Flow | -586,502 | -334,773 | -338,763 | -146,778 |
Cash | 99,134 | 248,402 | 204,877 | 76,057 |
Basic Shares | 91,234 | 71,200 | 44,741 | 39,375 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.71 |
2024-09-30 | -$1.74 |
2024-06-30 | -$3.50 |
2024-03-31 | -$2.20 |
